US$ 27.55
glp 1 agonist buy GLP-1 Essentials GLP-1 Receptor Agonist Market Growth
Description
Faillie JL, Yin H, Yu OHY, et al

Upon binding to their respective receptors on pancreatic beta cells, GIP and GLP-1 enhance insulin secretion in a glucose-dependent manner

In some cases, combining the two therapies can yield complementary results, though cost and tolerability remain considerations

Their once-weekly dosing and favorable safety profile further enhance adherence and adoption

Prices are already falling

* Target MAP 6570 mmHg (adjust to patients baseline)
